Assignee profile:

Pfizer Inc.

City:

Madison, New Jersey

Country:

United States

Published Applications:

22

Last publication date:

2013-08-01

Patent Grants:

17

Last grant date:

2015-02-03

Top Inventors for applications by Pfizer Inc.

These are the the leading inventors for applications assigned to Pfizer Inc.:

Recent patent applications by Pfizer Inc.

Pfizer Inc. based in Madison, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-08-01 ✅ Patent 8,946,413 granted on 2015-02-03
US20130197008A1
Chemistry; metallurgy

3-aminocyclopentanecarboxamides as chemokine receptor agonists

#2 | 2013-01-24 ✅ Patent 8,790,651 granted on 2014-07-29
US20130022616A1
Chemistry; metallurgy

Interleukin-31 monoclonal antibody

#3 | 2012-12-27 ✅ Patent 8,741,303 granted on 2014-06-03
US20120328639A1
Human necessities

Immunogenic LHRH compositions and methods relating thereto

#4 | 2012-12-20 ✅ Patent 8,846,388 granted on 2014-09-30
US20120321654A1
Human necessities

Infectious clones of torque teno virus

#5 | 2012-12-20
US20120321651A1
Human necessities

Anti-IGE Vaccines

#6 | 2012-10-11
US20120258976A1
Chemistry; metallurgy

CRYSTALLINE PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS

#7 | 2012-10-04 ✅ Patent 9,050,342 granted on 2015-06-09
US20120252825A1
Human necessities

Beneficial effects of combination therapy on cholesterol

#8 | 2012-10-04 ✅ Patent 9,149,520 granted on 2015-10-06
US20120251566A1
Human necessities

Saponin adjuvant compositions and methods relating thereto

#9 | 2012-05-03 ✅ Patent 8,431,138 granted on 2013-04-30
US20120107351A1
Human necessities

In ovo vaccination of in avian species

#10 | 2012-02-09
US20120035194A1
Chemistry; metallurgy

SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS

#11 | 2011-12-01 ✅ Patent 8,372,854 granted on 2013-02-12
US20110294826A1
Chemistry; metallurgy

Pyrrolo[2,3-D]pyrimidine compounds

#12 | 2011-12-01
US20110293647A1
Human necessities

IMMUNOGENIC LHRH COMPOSITIONS AND METHODS RELATING THERETO

#13 | 2011-06-09 ✅ Patent 8,633,206 granted on 2014-01-21
US20110136765A1
Chemistry; metallurgy

Pyrrolo[2,3-D]pyrimidine compounds

#14 | 2011-03-17 ✅ Patent 8,921,535 granted on 2014-12-30
US20110064758A1
Human necessities

Infectious clones of torque teno virus

#15 | 2011-01-27
US20110020909A1
Chemistry; metallurgy

Methods Of Culturing Lawsonia Intracellularis

#16 | 2010-05-06 ✅ Patent 8,273,356 granted on 2012-09-25
US20100113361A1
Human necessities

Anti-IgE vaccines

#17 | 2010-03-04 ✅ Patent 7,998,978 granted on 2011-08-16
US20100056506A1
Chemistry; metallurgy

Substituted 2-amino-fused heterocyclic compounds

#18 | 2010-02-11 ✅ Patent 7,842,699 granted on 2010-11-30
US20100035903A1
Chemistry; metallurgy

Pyrrolo[2,3-D]pyrimidine compounds

#19 | 2009-07-02 ✅ Patent 8,017,144 granted on 2011-09-13
US20090169595A1
Human necessities

Controlled release polymeric compositions of bone growth promoting compounds

#20 | 2009-01-01 ✅ Patent 7,879,337 granted on 2011-02-01
US20090004221A1
Chemistry; metallurgy

Mutant porcine reproductive and respiratory syndrome virus

#21 | 2006-06-08 ✅ Patent 7,897,733 granted on 2011-03-01
US20060121545A1
Chemistry; metallurgy

Rapamycin conjugates and antibodies

#22 | 2005-07-21 ✅ Patent 7,803,805 granted on 2010-09-28
US20050159434A1
Chemistry; metallurgy

Cristalline 3-{(3R,4R)-4 methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt

AssigneeID:

5866 ⎘